Overview

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
SHARE: Simple HAART with Abacavir, Reyataz, and Epivir
Phase:
Phase 4
Details
Lead Sponsor:
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Collaborator:
GlaxoSmithKline
Treatments:
Abacavir
Atazanavir Sulfate
Ritonavir